Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease

References

• AbramsonBLHuckellVAnandSCanadian Cardiovascular Society Consensus Conference: peripheral arterial disease – executive summaryCan J Cardiol200521997100616234879
   PubMed Web of Science ®Google Scholar
• Al OmranMLindsayTFMajorJPerceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial diseaseAnn Vasc Surg2006205556316871436
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationPosition statement. Standards of medical care for patients with diabetes mellitusDiabetes Care200326S335012502618
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ20023247329718611786451
   PubMed Web of Science ®Google Scholar
• CAPRIE Steering CommitteeA randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeLancet19963481329398918275
   PubMed Web of Science ®Google Scholar
• CassarKBelchJJBrittendenJAre national cardiac guidelines being applied by vascular surgeons?Eur J Vasc Endovasc Surg200326623814603422
   PubMed Web of Science ®Google Scholar
• CassarKCoullRBachooPManagement of secondary risk factors in patients with intermittent claudicationEur J Vasc Endovasc Surg200326262614509888
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRThe seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 reportJAMA200328925607212748199
   PubMed Web of Science ®Google Scholar
• CriquiMHLangerRDFronekAMortality over a period of 10 years in patients with peripheral arterial diseaseN Engl J Med199232638161729621
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• FowkesFGHousleyERiemersmaRASmoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery StudyAm J Epidemiol1992135331401550087
   PubMed Web of Science ®Google Scholar
• Heart Protection Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trialLancet2002360932672212114036
   PubMed Web of Science ®Google Scholar
• HirschATCriquiMHTreat-JacobsonDPeripheral arterial disease detection, awareness, and treatment in primary careJAMA200128613172411560536
   PubMed Web of Science ®Google Scholar
• HirschATGloviczkiPDroozAMandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular healthJ Vasc Surg2004394748114743158
   PubMed Web of Science ®Google Scholar
• HirschATHaskalZJHertzerNRACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease FoundationCirculation2006113e46365416549646
   PubMed Web of Science ®Google Scholar
• LuJTCreagerMAThe relationship of cigarette smoking to peripheral arterial diseaseRev Cardiovasc Med200451899315580157
   PubMedGoogle Scholar
• McDermottMMHahnEAGreenlandPAtherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician surveyJ Gen Intern Med20021789590412472925
   PubMed Web of Science ®Google Scholar
• MukherjeeDLingamPChetcutiSMissed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)Circulation200210619091212370211
   PubMed Web of Science ®Google Scholar
• SmithSCJrAllenJBlairSNAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood InstituteCirculation200611323637216702489
   PubMed Web of Science ®Google Scholar
• SmithSCJrBlairSNBonowROAHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of CardiologyJ Am Coll Cardiol2001381581311691544
   PubMed Web of Science ®Google Scholar
• StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ20003214051210938048
   PubMed Web of Science ®Google Scholar
• The TASC Working GroupManagment of peripheral arterial disease (PAD); Trans Atlantic Inter-Society Consensus (TASC)J Vasc Surg200131(1 Part 2) SupplS1288
   Web of Science ®Google Scholar
• WilligendaelEMTeijinkJABartelinkMLInfluence of smoking on incidence and prevalence of peripheral arterial diseaseJ Vasc Surg20044011586515622370
   PubMed Web of Science ®Google Scholar
• WilterdinkJLEastonJDVascular event rates in patients with atherosclerotic cerebrovascular diseaseArch Neurol199249857631524519
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med20003421455310639539
   PubMed Web of Science ®Google Scholar